Assessment of low level whole-body soman vapor exposure in rats

Neurotoxicology and Teratology

Volumn 31, Issue 2, 2009, Pages 110-118

  Genovese, Raymond F ^a   Benton, Bernard J ^b   Johnson, Christina C ^a   Jakubowski, E Michael ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b EDGEWOOD CHEMICAL BIOLOGICAL CENTER   (United States)

Author keywords

Cognition; GD; Memory; Nerve agent; Performance; Soman

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; SOMAN;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BLOOD SAMPLING; CELL FRACTIONATION; CONTROLLED STUDY; CONVULSION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ERYTHROCYTE; EXPOSURE; MALE; MAZE TEST; MIOSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SPRAGUE DAWLEY RAT; TASK PERFORMANCE;

ACETYLCHOLINESTERASE; ANIMALS; BUTYRYLCHOLINESTERASE; CHEMICAL WARFARE AGENTS; CONDITIONING, OPERANT; INHALATION EXPOSURE; MALE; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; SOMAN;

RATTUS;

EID: 61849137808     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.10.003     Document Type: Article

References (56)

1. Adams T.K., Capacio B.R., Smith J.R., Whalley C.E., and Korte W.D. The application of the fluoride reactivation processes to the detection of sarin and soman nerve agent exposures in biological samples. Drug. Chem. Toxicol. 27 (2004) 77-91
2. Bajgar J., Sevelová L., Krejcová G., Fusek J., Vachek J., Kassa J., Herink J., de Jong L.P., and Benschop H.P. Biochemical and behavioral effects of soman vapors in low concentrations. Inhal. Toxicol. 16 (2004) 497-507
3. Barch D.M. Pharmacological manipulation of human working memory. Psychopharmacol. 174 (2004) 126-135
4. Bizot J.C. Effects of various drugs including organophosphorus compounds (OPC) and therapeutic compounds against OPC on DRL responding. Pharmacol. Biochem. Behav. 59 (1998) 1069-1080
5. Black R.M., Harrison J.M., and Read R.W. The interaction of sarin and soman with plasma proteins: the identification of a novel phosphonylation site. Arch. Toxicol. 73 (1999) 123-126
6. Bowers M.B., Goodman E., and Sim V.M. Some behavioral changes in man following anticholinesterase administration. J. Nerv. Ment. Dis 138 (1964) 383-389
7. Braida D., Ottonello F., and Sala M. Eptastigmine improves eight-arm radial maze performance in aged rats. Pharmacol. Res. 42 (2000) 299-304
8. Dabisch P.A., Burnett D.C., Miller D.B., Jakubowski E.M., Muse W.T., Forster J.S., Scotto J.A., Jarvis J.R., Davis E.A., Hulet S.W., Reutter S.A., Mioduszewski R.J., and Thomson S.A. Tolerance to the miotic effect of sarin vapor in rats after multiple low-level exposures. J. Ocular. Pharmacol. Ther. 21 (2005) 182-195
9. Dabisch P.A., Horsmon M.S., Taylor J.T., Muse W.T., Miller D.B., Sommerville D.R., Mioduszewski R.J., and Thomson S.A. Gender difference in the miotic potency of soman vapor in rats. Cutan. Ocul. Toxicol. 27 (2008) 123-133
10. Dachir S., Schmidt B., and Levy A. Effects of metrifonate on radial arm maze acquisition in middle-aged rats. Brain. Res. 777 (1997) 251-254
11. De Jong L.P.A., and Benschop H.P. Biochemical and toxicological implications of chirality in anticholinesterase organophosphates. In: Ariëns E.J., van Rensen J.J.S., and Welling W. (Eds). Stereoselectivity of Pesticides; Biological and Chemical Problems (1988), Elsevier Science Publishers B.V., Amsterdam 109-149
12. De Jong L.P.A., and Van Dijk C. Formation of soman (1,2,2-trimethylpropyl methylphosphonofluoridate) via fluoride-induced reactivation of soman-inhibited aliesterase in rat plasma. Biochem. Pharmacol. 33 (1984) 663-669
13. Ellman G.L., Courtney K.D., Andres V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholesterase activity using thiocholine esters as substrates. Biochem. Pharmacol. 7 (1961) 88-95
14. Fitzgerald R.E., Berres M., and Schaeppi U. Validation of a radial maze test for assessing learning and memory in rats. Toxicol. 49 (1988) 425-432
15. Genovese R.F. Effects of azaprophen, scopolamine, and trihexyphenidyl, in rats, before and after chronic physostigmine. Eur. J. Pharmacol. 176 (1990) 271-279
16. Genovese R.F., and Doctor B.P. Behavioral and pharmacological evaluation of butyrylcholinesterase in rats. Pharmacol. Biochem. Behav. 51 (1995) 647-654
17. Genovese R.F., Elsmore T.F., and King L.R. Tolerance to oxotremorine's effects on schedule-controlled behavior in physostigmine-tolerant rats. Life. Sci. 43 (1988) 571-576
18. Genovese R.F., Elsmore T.F., and Witkin J.M. Environmental influences on the development of tolerance to the effects of physostigmine on schedule-controlled behavior. Psychopharmacol. (Berl) 96 (1988) 462-467
19. Genovese R.F., Elsmore T.F., and Witkin J.M. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine. Pharmacol. Biochem. Behav. 37 (1990) 117-122
20. Genovese R.F., Benton B.J., Shippee S.J., Jakubowski E.M., and Bonnell J.C. Effects of low-level inhalation exposure to GF on learned behaviors in rats. J. Toxicol. Environ. Health 69 (2006) 2167-2180
21. Genovese R.F., Benton B.J., Lee E.H., Shippee S.J., and Jakubowski E.M. Behavioral and biochemical evaluation of sub-lethal inhalation exposure to VX in rats. Toxicol. 232 (2007) 109-118
22. Genovese R.F., Oubre J.L., Jakubowski E.M., Fleming P.J., Saxena A., Rockwood G.A., Tipparaju P., and Willmore C.B. Evaluation of cognitive and biochemical effects of low-level exposure to sarin in rhesus and African green monkeys. Toxicol. 231 (2007) 11-20
23. Genovese R.F., Benton B.J., Oubre J.L., Fleming P.J., Jakubowski E.M., and Mioduszewski R.J. Determination of miosis threshold from whole-body vapor exposure to sarin in African green monkeys. Toxicol. 244 (2008) 123-132
24. R.F. Genovese, R.J. Mioduszewski, J.B. Benton, M.A. Pare, J.A. Cooksey, Behavioral evaluation of rats following low-level inhalation exposure to sarin, Pharmacol. Biochem. Behav. (in press). doi:10.1016/j.pbb.2008.09.006.
25. Harris L.W., Fleisher J.H., Clark J., and Cliff W.J. Dealkylation and loss of capacity for reactivation of cholinesterase inhibited by sarin. Science 154 (1966) 404-407
26. Hatta K., Miura Y., Asukai N., and Hamabe Y. Amnesia from sarin poisoning. Lancet 347 (1996) 1343
27. Henderson R.F., Barr E.B., Blackwell W.B., Clark C.R., Conn C.A., Kalra R., March T.H., Sopori M.L., Tesfaigzi Y., Menache M.G., Mash D.C., Dokladny K., Kozak W., Kozak A., Wachulec M., Rudolph K., Kluger M.J., Singh S.P., Razani-Boroujerdi S., and Langley R.J. Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illness. Toxicol. Ind. Health 17 (2001) 294-297
28. Henderson R.F., Barr E.B., Blackwell W.B., Clark C.R., Conn C.A., Kalra R., March T.H., Sopori M.L., Tesfaigzi Y., Ménache M.G., and Mash D.C. Response of rats to low levels of sarin. Toxicol. Appl. Pharmacol. 184 (2002) 67-76
29. Holstege C.P., Kirk M., and Sidell F.R. Chemical warfare nerve agent poisoning. Crit. Care Clin. 13 (1997) 923-942
30. Hymowitz N., Ploshnick A., Laemle L., and Brezenoff H. Effects of repeated administration of soman on schedule-controlled behavior and brain in the rat. Neurotoxicol. Teratol. 12 (1990) 47-56
31. Jakubowski E.M., McGuire J.M., Evans R.A., Edwards J.L., Hulet S.W., Benton B.J., Forester J.S., Burnett D.C., Muse W.T., Matson K., Crouse C.L., Mioduszewski R.J., and Thomson S.A. Quantitation of fluoride ion released sarin in red blood cell samples by gas chromatography-chemical ionization mass spectrometry using isotope dilution and large volume injection. J. Anal. Toxicol. 28 (2004) 357-363
32. Joanovic M., Kosanovic M., and Maksimovic M. Interaction of organophosphorus compounds with carboxylesterases in the rat. Arch. Toxicol. 70 (1996) 444-450
33. Kassa J., Koupilova M., Herink J., and Vachek J. The long-term influence of low-level sarin exposure on behavioral and neurophysiological functions in rats. Acta. Medica. (Hradec Kralove) 44 (2001) 21-27
34. Kassa J., Koupilova M., and Vachek J. Long-term effects of low-level sarin inhalation exposure on the spatial memory of rats in a T-maze. Acta. Medica. (Hradec Kralove) 44 (2001) 93-96
35. Kassa J., Pecka M., Tichy M., Bajgar J., Koupilova M., Herink J., and Krocova Z. Toxic effects of sarin in rats at three months following single or repeated low-level inhalation exposure. Pharmacol. Toxicol. 88 (2001) 209-212
36. Langston J.L., Adkins A.L., Moran A.V., Rockwood G.A., and Deford M.S. Effects of sarin on the operant behavior of guinea pigs. Neurotoxicol. Teratol. 27 (2005) 841-853
37. Luo C., Tong M., Chilukuri N., Brecht K., Maxwell D.M., and Saxena A. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes. Biochem. 46 (2007) 11771-11779
38. Maxwell D.M. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol. 114 (1992) 306-312
39. Nishiwaki Y., Maekawa K., Ogawa Y., Asukai N., Minami M., and Omae K. Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack. Environ. Health Perspect. 109 (2001) 1169-1173
40. Oberist F.W., and Christenson M.K. Regeneration of erythrocyte and brain cholinesterase activity in rats after sub-lethal exposures to GB vapors. J. Pharmacol. Exp. Ther. 116 (1956) 216-219
41. Olton D.S. The radial arm maze as a tool in behavioral pharmacology. Physiol. Behav. 40 (1987) 793-797
42. Peeples E.S., Schopfer L.M., Duysen E.G., Spaulding R., Voelker T., Thompson C.M., and Lockridge O. Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol. Sci. 83 (2005) 303-312
43. Renner J.A., Dabisch P.A., Evans R.A., McGuire J.M., Totura A.L., Jakubowski E.M., and Thomson S.A. Validation and application of a GC-MS method for determining soman concentration in rat plasma following low-level vapor exposure. J. Anal. Toxicol. 32 (2008) 92-98
44. Shafferman A., Ordentlich A., Barak D., Stein D., Ariel N., and Velan B. Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre. Biochem. J. 318 (1996) 833-840
45. Sidell F.R. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin. Toxicol. 7 (1974) 1-17
46. Sidell F.R. Clinical considerations in nerve agent intoxication. In: Somani S.M. (Ed). Chemical Warfare Agents (1992), Academic Press, San Diego 155-194
47. Sidell F.R. Nerve agents. In: Zajtchuk R., and Bellamy R.F. (Eds). Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare (1997), Office of the Surgeon General, Department of the Army, Washington DC 141-179
48. Talbot B.G., Anderson D.R., Harris L.W., Yarbrough L.W., and Lennox W.J. A comparison of in vivo and in vitro rates of aging of soman-inhibited erythrocyte acetylcholinesterase in different animal species. Drug. Chem. Toxicol. 11 (1988) 289-305
49. Trifunović A., Zarić J., Lusić M., Mijatović M., Glisin V., and Popović Z. Induced synthesis of albumin-like protein in damaged rat reticulocytes. Br. J. Haematol. 115 (2001) 205-212
50. van der Schans M.J., Polhuisjs M., van Dijk C., Degenhardt C.E., Pleijseir K., Langenberg J.P., and Benschop H.P. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch. Toxicol. 78 (2004) 508-524
51. Walsh T.J., and Chrobak J.J. The use of the radial arm maze in neurotoxicology. Physiol. Behav. 40 (1987) 799-803
52. Whalley C.E., McGuire J.M., Miller D.B., Jakubowski E.M., Mioduszewski R.J., Thomson S.A., Lumley L.A., McDonough J.H., and Shih T.M. Kinetics of sarin (GB) following a single sublethal inhalation exposure in the guinea pig. Inhal. Toxicol. 19 (2007) 667-681
53. Williams N.H., Harrison J.M., Read R.W., and Black R.M. Phosphylated tyrosine in albumin as a biomarker of exposure to organophosphorus nerve agents. Arch. Toxicol. 81 (2007) 627-639
54. Woodard C.L., Calamaio C.A., Kaminskis A., Anderson D.R., Harris L.W., and Martin D.G. Erythrocyte and plasma cholinesterase activity in male and female rhesus monkeys before and after exposure to sarin. Fund. Appl. Toxicol. 23 (1994) 342-347
55. Worek F., Eyer P., and Szinicz L. Inhibition, reactivation and aging kinetics of cyclohexylmethylphosphonofluoridate-inhibited human cholinesterases. Arch. Toxicol. 72 (1998) 580-587
56. Yokoyama K., Araki S., Murata K., Nishikitani M., Okumura T., Ishimatsu S., and Takasu N. Chronic neurobehavioral and central and autonomic nervous system effects of Tokyo subway sarin poisoning. J. Physiol. Paris 92 (1998) 317-323